Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.
about
High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation.Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
P2860
Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Phase-1 study of siplizumab in ...... ute graft-versus-host disease.
@en
type
label
Phase-1 study of siplizumab in ...... ute graft-versus-host disease.
@en
prefLabel
Phase-1 study of siplizumab in ...... ute graft-versus-host disease.
@en
P2093
P2860
P1476
Phase-1 study of siplizumab in ...... ute graft-versus-host disease.
@en
P2093
Gregory P Geba
Harry Yang
Joel A Brochstein
Stanley R Pillemer
Stephan Grupp
P2860
P304
P356
10.1111/J.1399-3046.2009.01223.X
P577
2009-08-11T00:00:00Z